Research, Select, & Monitor Saturday, January 18, 2020 11:50:22 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Eli Lilly & Co.$139.58($1.85)(1.31%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Eli Lilly & Co. vs Drug Manufacturers / Major

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Most of the firms here are multi-billion dollar companies that provide America and the world with a majority of the drugs they take on what is sometimes a daily basis. These companies usually have their own laboratories that design and develop new and innovative drugs for use in medicine. The research projects their own labs can not handle are typically contracted out to smaller clinical research firms who specialize in pharmaceuticals. Profit margins can be very high in this industry, which has helped fund the enormous amounts of research required to develop a new prescription drug.
 Totals Company Industry
  Sales: N/A N/A
  Market Cap: $134,014.9 Mil $1,722,482.9 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
  Historic Revenue: N/A N/A
  Estimated Revenue: N/A N/A
  Historic Earnings: N/A N/A
  Estimated Earnings: N/A N/A
  Stock Price (1 Year): 17.1% 20.2%
  Cash per Share: N/A N/A
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 20.6 17.9
  Price-to-Sales: N/A N/A
  Price-to-Book: N/A N/A
  Dividend Yield: N/A N/A
  Market Cap: $134,014.9 Mil $191,387.0 Mil
  Net Margin: N/A N/A
  Gross Margin: N/A N/A
  Return on Equity: N/A N/A
  Return on Assets: N/A N/A
  Balance Sheet
  Current Ratio: N/A N/A
  Quick Ratio: N/A N/A
  Cash Ratio: N/A N/A
  Debt-to-Equity: N/A N/A
  Interest Coverage: N/A N/A
  Relative-Strength Index: 81.2 N/A

 Other companies in Drug Manufacturers / Major Price Market Cap
  Johnson & Johnson  (JNJ) $149.17 $392,596.0 Mil
  Merck & Co., Inc.  (MRK) $90.97 $231,607.8 Mil
  Pfizer, Inc.  (PFE) $40.51 $224,187.2 Mil
  Novartis International AG  (NVS) $95.93 $219,852.4 Mil
  Abbott Laboratories  (ABT) $89.00 $157,392.9 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2020 All rights reserved.